Substituted arylamide diazepinopyrimidone derivatives for the treatment of neurodegenerative diseases caused by abnormal activity of GSK3-beta

Details for Australian Patent Application No. 2009208728 (hide)

Owner MITSUBISHI TANABE PHARMA CORPORATION SANOFI-AVENTIS

Inventors Fayol, Aude; Vache, Julien; Yaiche, Philippe; Saady, Mourad; Lochead, Alistair

Agent A J Park

Pub. Number AU-A-2009208728

PCT Pub. Number WO2009/095789

Priority 08290074.7 29.01.08 EP

Filing date 27 January 2009

Wipo publication date 6 August 2009

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

19 August 2010 PCT application entered the National Phase

  PCT publication WO2009/095789 Priority application(s): WO2009/095789

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009208729-Preparation of terminally-sterilized collagen that is soluble at neutral pH

2009208727-Substituted arylamide oxazepinopyrimidone derivatives